LivaNova (LIVN) Divestments (2018 - 2021)

LivaNova (LIVN) reported Divestments of $2.7 million for Q4 2021, up 278.28% sequentially from -$1.5 million in Q3 2021.

LivaNova (LIVN) Divestments (2018 - 2021) Analysis & Trends

LivaNova (LIVN) has 2 years of Divestments data on file, last reported at $2.7 million in Q4 2021.

For the quarter ending Q4 2021, Divestments changed N/A year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2022 stood at $1.2 million (down 94.02% YoY), and the FY2021 full-year result was $42.9 million, changed N/A from the prior year.
Divestments grew to $2.7 million in Q4 2021, from -$1.5 million in the prior quarter.
In the past five years, Divestments ranged from a high of $173.4 million in Q2 2018 to a low of -$1.5 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	9.37 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	LivaNova	4.30 Bn	3.76 Bn	243.75 Mn	-

Download Data